Loading organizations...
Loading organizations...
Biopharmaceutical company developing safer therapies for CNS diseases.
Zevra Therapeutics has raised $63.8M across 2 funding rounds.
Zevra Therapeutics has raised $63.8M in total across 2 funding rounds.
Zevra Therapeutics has raised $63.8M in total across 2 funding rounds.
Zevra Therapeutics's investors include Jonathan Leff, DeWaay Investment Partners.
Zevra Therapeutics has raised $63.8M across 2 funding rounds. Most recently, it raised $60.0M Debt / Other Equity in June 2014.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 3, 2014 | $60.0M Debt / Other Equity | Jonathan Leff | |
| Sep 16, 2009 | $3.8M Series B | DeWaay Investment Partners |